Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

NCT02155660 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2255

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Benralizumab Arm A
DRUG: Benralizumab Arm B
DRUG: Benralizumab Arm C
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]